Apple

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

The company will use the investment to scale its platform and expand its proprietary database.

The Patent Trial and Appeal Board determined three AliveCor patents regarding the detection of heart conditions like cardiac arrhythmias were unpatentable.

The company’s Polso wrist-worn wearable allows for the collection of blood oxygen saturation, respiration rate and pulse rate.

The study identified associations between abnormal uterine bleeding patterns, demographics and medical conditions.

In a letter to CEO Tim Cook, ten state attorneys general called on the tech giant to require stricter privacy standards for third-party apps hosted on the App Store.

The Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial will study a "pill-in-pocket" method of stroke prevention for patients with atrial fibrillation. Some participants will monitor for AFib using an Apple Watch and take blood thinners as needed, instead of using the drug continuously.

The Series 8 includes two temperature sensors that can be used to retrospectively estimate when ovulation occurred.

Shipments of wearables declined 3% year-over-year, according to a report by the International Data Corporation.

The tech giant also announced a new atrial fibrillation history feature and sleep stage tracking.